Yes
—
No
—
Voting closed
Voting is closed.
Votes only — no stakes, just conviction.
✨ AI says 38% Yes
Cancer and immunotherapy are perennial contenders, but the Nobel often rewards novel mechanisms across broader categories; prediction is speculative.
Rules
Resolves YES if the official Nobel Prize announcement at nobelprize.org cites cancer research, immunotherapy for cancer, or tumor biology as the primary citation for the 2026 award.
Share this with an ambitious friend